The Effects of Targeted Temperature Management on Oxygen-Glucose DeprivationReperfusion-Induced Injury and DAMP Release in Murine Primary Cardiomyocytes

Abstract EN

Introduction.

Ischemia/Reperfusion (I/R) is a primary cause of myocardial injury after acute myocardial infarction resulting in the release of damage-associated molecular patterns (DAMPs), which can induce a sterile inflammatory response in the myocardial penumbra.

Targeted temperature management (TTM) after I/R has been established for neuroprotection, but the cardioprotective effect remains to be elucidated.

Therefore, we investigated the effect of TTM on cell viability, immune response, and DAMP release during oxygen-glucose deprivation/reperfusion (OGD/R) in murine primary cardiomyocytes.

Methods.

Primary cardiomyocytes from P1-3 mice were exposed to 2, 4, or 6 hours OGD (0.2% oxygen in medium without glucose and serum) followed by 6, 12, or 24 hours simulated reperfusion (21% oxygen in complete medium).

TTM at 33.5°C was initiated intra-OGD, and a control group was maintained at 37°C normoxia.

Necrosis was assessed by lactate dehydrogenase (LDH) release and apoptosis by caspase-3 activation.

OGD-induced DAMP secretions were assessed by Western blotting.

Inducible nitric oxide synthase (iNOS), cytokines, and antiapoptotic RBM3 and CIRBP gene expressions were measured by quantitative polymerase chain reaction.

Results.

Increasing duration of OGD resulted in a transition from apoptotic programmed cell death to necrosis, as observed by decreasing caspase-3 cleavage and increasing LDH release.

DAMP release and iNOS expression correlated with increasing necrosis and were effectively attenuated by TTM initiated during OGD.

Moreover, TTM induced expression of antiapoptotic RBM3 and CIRBP.

Conclusion.

TTM protects the myocardium by attenuating cardiomyocyte necrosis induced by OGD and caspase-3 activation, possibly via induction of antiapoptotic RBM3 and CIRBP expressions, during reperfusion.

OGD induces increased Hsp70 and CIRBP releases, but HMGB-1 is the dominant mediator of inflammation secreted by cardiomyocytes after prolonged exposure.

TTM has the potential to attenuate DAMP release.